Scope Fluidics S.A. (WSE:SCP)
Poland · Delayed Price · Currency is PLN 116.60
-0.60 (-0.51%)
May 27, 2026, 12:33 PM CET
Scope Fluidics Market Cap
Scope Fluidics has a market cap or net worth of 371.32 million as of May 27, 2026. Its market cap has decreased by -19.49% in one year.
Market Cap
371.32M
Enterprise Value
235.38M
Revenue
104.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
116.60
Market Cap Chart
Since August 16, 2017, Scope Fluidics's market cap has increased from 41.31M to 371.32M, an increase of 798.78%. That is a compound annual growth rate of 28.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 371.32M | -13.95% |
| Dec 30, 2025 | 431.52M | -3.47% |
| Dec 30, 2024 | 447.05M | -16.33% |
| Dec 29, 2023 | 534.28M | -5.54% |
| Dec 30, 2022 | 565.63M | 54.38% |
| Dec 30, 2021 | 366.40M | 1.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.58B |
| NEUCA | 3.42B |
| Synektik Spólka Akcyjna | 2.44B |
| Celon Pharma | 1.13B |
| Centrum Medyczne ENEL-MED | 545.81M |
| Captor Therapeutics Spolka Akcyjna | 495.56M |
| Ryvu Therapeutics | 409.23M |
| Bioceltix | 396.91M |